Table 1.
Demographics and clinical characteristics of severe COVID-19
| Variables | Median (IQR), or N (%) |
|---|---|
| Patients (n = 100) | |
| Age, y | |
| Median (IQR) | 62.0 (51.0–70.8) |
| < 60 | 40 (40.0) |
| ≥ 60 | 60 (60.0) |
| Sex | |
| Male | 56 (56.0) |
| Female | 44 (44.0) |
| Comorbidities | 69 (69.0) |
| Hypertension | 40 (40.0) |
| Diabetes | 21 (21.0) |
| CVD | 15 (15.0) |
| COPD | 12 (12.0) |
| Malignancy | 13 (13.0) |
| Hypothyroidism | 2 (2.0) |
| Liver cirrhosis | 3 (3.0) |
| Hyperlipidemia | 2 (2.0) |
| Anemia | 2 (2.0) |
| Initial symptoms | |
| Fever | 69 (69.0) |
| Cough | 63 (63.0) |
| Chest distress | 13 (13.0) |
| Fatigue | 12 (12.0) |
| Sputum | 7 (7.0) |
| Myalgia | 5 (5.0) |
| Dyspnea | 6 (6.0) |
| Headache | 4 (4.0) |
| Sore throat | 4 (4.0) |
| Chest pain | 2 (2.0) |
| Diarrhea | 3 (3.0) |
| Nausea | 3 (3.0) |
| SBP, mmHg | 135.0 (122.0–149.0) |
| DBP, mmHg | 81.5 (74.8–91.0) |
| Heart rate, bpm | 92.5 (79.5–103.3) |
| SPO2, %§ | 97.0 (95.0–98.0) |
| ≤ 93.0 | 10 (10.0) |
| Days from illness onset to admission | 14.0 (7.0–28.0) |
| Hospitalization time, day | 21.0 (15.0–39.5) |
§Oxygen saturation was measured on admission after receiving oxygen therapy. COVID-19 = coronavirus disease 2019; COPD = chronic obstructive pulmonary disease; CVD = cardiovascular disease; SBP = systolic blood pressure; DBP = diastolic blood pressure